Valganciclovir as preemptive therapy for
β
Nina Singh; Cheryl Wannstedt; Lois Keyes; Debra Mayher; Lisa Tickerhoof; Mohamed
π
Article
π
2008
π
John Wiley and Sons
π
English
β 82 KB
The efficacy of valganciclovir as preemptive therapy for the prevention of cytomegalovirus (CMV) disease and its impact on indirect sequelae of CMV were assessed in recipient-negative/donor-positive (RΟͺ/DΟ©) liver transplant recipients. Of 187 consecutive liver transplant recipients at our institutio